APR 18, 2020 4:14 PM PDT

A New Double Threat Against Skin Cancer

WRITTEN BY: Jasper Cantrell

Skin cancer is one of the most common cancers in America. One of the most aggressive forms of skin cancer is melanoma, accounting for up to 85% of skin cancer deaths and a poor two-year prognosis. A few treatments are available, from chemotherapy to immunotherapy; however, the prognosis remains grim. A group from China decided to investigate an up and coming chemotherapy, alteronol, against melanoma. In particular, they were curious as to how it’s of autophagic activity might affect its anti-cancer activities.

Alteronol is a drug that has the same origins as another frontline chemotherapy Paclitaxel. Previous research has found it to be effective against many cancers, including melanoma. The primary activities that give it its anti-tumor abilities revolve around inducing apoptosis in cancer cells, as well as preventing metastasis through suppressing cellular migration. One of its lesser-known activities is autophagy, which conversely is linked to cancer progression. Alteronol’s autophagy activity would, therefore, be a target for study.

Using melanoma cell lines, they found that the addition of alteronol preferentially hindered the growth of cancer cells over normal cells. Alteronol’s apoptotic activity was confirmed by measuring levels of apoptotic proteins upon its application. The group then began looking at the Akt/mTOR pathway as a possible reason for alteronol’s autophagic activities. The Akt/mTOR is a known regulatory pathway of autophagy, and it was found that alteronol seemed to suppress its activation. This observation led the team to introduce a second drug, 3-MA, to prevent this suppression. The addition of both alteronol and 3-MA unexpectedly showed higher apoptotic activity. This dual treatment also enhanced alteronol’s inhibition of cellular migration and invasion. Wrapping it all together, the group ran mouse experiments that confirmed that while alteronol alone could decrease tumor growth, the dual treatment was shown to be an even greater suppresser of tumor growth.

The prevalence of skin cancer makes the poor prognosis of its most aggressive form a frightening concept. With prevention with sunscreen and regular checkups having the best results, treatments for skin cancer itself are comparably ineffective. Therefore, the dual treatment found from this investigation could be a literal lifesaver. The group concludes, “Our results demonstrated that alteronol is an effective anti-melanoma agent both in vitro and in vivo, and the combination of alteronol and autophagy inhibitor 3-MA may have multiple beneficial effects as a potential treatment for melanoma.”

Sources: Nature, Mayo Clinic

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
JUN 27, 2021
Cancer
Are e-cigarettes actually helpful for smoking cessation?
JUN 27, 2021
Are e-cigarettes actually helpful for smoking cessation?
New research published in The Lancet Public Health reports on a study that looked at interventions targeting e-cigarette ...
JUL 13, 2021
Clinical & Molecular DX
Friend or Foe? New Cancer-Tracking Pen Guides Surgeons.
JUL 13, 2021
Friend or Foe? New Cancer-Tracking Pen Guides Surgeons.
Researchers have developed the first diagnostic “pen” that acts as a guide for surgeons, helping them distin ...
AUG 19, 2021
Immunology
Immune Enzyme Kills Viruses but Makes Tumors Stronger
AUG 19, 2021
Immune Enzyme Kills Viruses but Makes Tumors Stronger
Robert Louis Stevenson’s 1886 novel Strange Case of Dr. Jekyll and Mr. Hyde describes a man who is a kind, respect ...
AUG 24, 2021
Clinical & Molecular DX
A New Chapter in Metastatic Breast Cancer Biomarkers
AUG 24, 2021
A New Chapter in Metastatic Breast Cancer Biomarkers
For patients diagnosed with metastatic breast cancer, it’s often not the primary tumor that has fatal consequences ...
SEP 16, 2021
Cancer
Inspiring Hope during Childhood Cancer Awareness Month
SEP 16, 2021
Inspiring Hope during Childhood Cancer Awareness Month
Childhood cancers, also known as pediatric cancers, are diagnosed in patients up to 14 years old.  Estimates for 20 ...
SEP 15, 2021
Cell & Molecular Biology
The Molecular 'Anchors' That Hold Cells in Place
SEP 15, 2021
The Molecular 'Anchors' That Hold Cells in Place
Cells in the body are held in place with a kind of molecular anchor, called focal adhesions, where cells are linked to c ...
Loading Comments...